Balance Sheet Tate & Lyle plc

Equities

TATE

GB00BP92CJ43

Food Processing

Real-time Estimate Cboe Europe Other stock markets 07:25:26 2025-12-15 am EST			5-day change	1st Jan Change
366.30 ^GBX	+0.30%		+0.33%	-43.59%

Dec. 03	4imprint appoints Topps Tiles Chair Paul Forman as chair from March	AN
Dec. 03	HSBC names new chair; Smiths sells Smiths Detection	AN

986ab53.Rom00kv8ko1xhj2I_CJ4npx7s_r729F8PqDVJTtqZ5w.IOWDhAmIpekk03_FkEsnru1D1r-qq5suWvqGdk0wJu0r0PC4fo_qvCK1BQ

Published financial data: TATE & LYLE PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2.81B	1.38B	1.75B	1.65B	1.74B
Total Revenues	2.81B	1.38B	1.75B	1.65B	1.74B
Cost of Goods Sold, Total	1.66B	696M	876M	796M	825M
Gross Profit	1.14B	679M	875M	851M	911M
Selling General & Admin Expenses, Total	182M	263M	287M	265M	321M
Provision for Bad Debts	-2M	-	-	-	-
R&D Expenses	43M	-	-	-	-
Depreciation & Amortization - (IS)	142M	56M	59M	58M	86M
Amortization of Goodwill and Intangible Assets - (IS)	33M	24M	36M	36M	42M
Other Operating Expenses	412M	173M	270M	261M	211M
Other Operating Expenses, Total	810M	516M	652M	620M	660M
Operating Income	332M	163M	223M	231M	251M
Interest Expense, Total	-26M	-23M	-29M	-22M	-35M
Interest And Investment Income	1M	1M	12M	19M	20M
Net Interest Expenses	-25M	-22M	-17M	-3M	-15M
Income (Loss) On Equity Invest.	26M	-	-24M	25M	-
Currency Exchange Gains (Loss)	-	-2M	-1M	-	-1M
Other Non Operating Income (Expenses)	-	-	-	-	-14M
EBT, Excl. Unusual Items	333M	139M	181M	253M	221M
Restructuring Charges	-20M	-1M	-5M	-21M	-72M
Merger & Related Restructuring Charges	-	-	-	-2M	-80M
Impairment of Goodwill	-	-	-	-	-
Asset Writedown	-8M	-17M	-1M	-1M	-
Insurance Settlements	2M	-	-	-	-
Legal Settlements	-5M	-	3M	-	-
Other Unusual Items	-19M	-79M	-26M	-3M	19M
EBT, Incl. Unusual Items	283M	42M	152M	226M	88M
Income Tax Expense	30M	16M	25M	47M	43M
Earnings From Continuing Operations	253M	26M	127M	179M	45M
Earnings Of Discontinued Operations	-	210M	63M	9M	95M
Net Income to Company	253M	236M	190M	188M	140M
Minority Interest	-	-	-	-	3M
Net Income - (IS)	253M	236M	190M	188M	143M
Net Income to Common Incl Extra Items	253M	236M	190M	188M	143M
Net Income to Common Excl. Extra Items	253M	26M	127M	179M	48M
Per Share Items
Net EPS - Basic	0.64	0.59	0.47	0.47	0.35
Basic EPS - Continuing Operations	0.64	0.07	0.31	0.45	0.12
Basic Weighted Average Shares Outstanding	398M	399M	404M	397M	409M
Net EPS - Diluted	0.63	0.59	0.46	0.47	0.34
Diluted EPS - Continuing Operations	0.63	0.06	0.31	0.44	0.12
Diluted Weighted Average Shares Outstanding	402M	403M	411M	404M	415M
Normalized Basic EPS	0.52	0.22	0.28	0.4	0.34
Normalized Diluted EPS	0.52	0.22	0.27	0.39	0.34
Dividend Per Share	0.36	0.22	0.18	0.19	0.2
Payout Ratio	54.15	61.02	38.42	40.43	55.94
American Depositary Receipts Ratio (ADR)	4	4	4	4	4
Supplemental Items
EBITDA	478M	250M	296M	303M	356M
EBITA	365M	189M	246M	254M	280M
EBIT	332M	163M	223M	231M	251M
EBITDAR	479M	-	-	-	-
Effective Tax Rate - (Ratio)	10.6	38.1	16.45	20.8	48.86
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	48M	36M	45M	71M	36M
Total Deferred Taxes	-18M	-20M	-20M	-24M	7M
Normalized Net Income	208M	86.88M	113M	158M	141M
Interest on Long-Term Debt	6M	2M	2M	2M	2M
Non-Cash Pension Expense	7M	-8M	5M	3M	5M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	43M	41M	46M	44M	50M
Net Rental Expense, Total	1M	-	-	-	-
Imputed Operating Lease Interest Expense	275K	-	-	-	-
Imputed Operating Lease Depreciation	725K	-	-	-	-
Stock-Based Comp., Other (Total)	8M	12M	20M	13M	12M
Total Stock-Based Compensation	8M	12M	20M	13M	12M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	371M	110M	475M	437M	334M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	371M	110M	475M	437M	334M
Accounts Receivable, Total	295M	223M	278M	233M	318M
Other Receivables	35M	42M	66M	48M	57M
Total Receivables	330M	265M	344M	281M	375M
Inventory	532M	317M	446M	353M	581M
Prepaid Expenses	14M	16M	16M	16M	23M
Other Current Assets, Total	55M	1.68B	3M	-	4M
Total Current Assets	1.3B	2.39B	1.28B	1.09B	1.32B
Gross Property Plant And Equipment	3.33B	1.33B	1.48B	1.54B	2.52B
Accumulated Depreciation	-2.22B	-831M	-996M	-1.01B	-1.1B
Net Property Plant And Equipment	1.1B	497M	488M	528M	1.42B
Long-term Investments	163M	46M	241M	193M	28M
Goodwill	228M	203M	308M	296M	518M
Other Intangibles, Total	126M	80M	123M	91M	278M
Deferred Tax Assets Long-Term	32M	9M	13M	28M	36M
Deferred Charges Long-Term	-	-	21M	19M	19M
Other Long-Term Assets, Total	20M	27M	29M	40M	111M
Total Assets	2.98B	3.25B	2.51B	2.28B	3.73B
Liabilities
Accounts Payable, Total	267M	151M	250M	174M	233M
Accrued Expenses, Total	120M	124M	106M	67M	106M
Short-term Borrowings	15M	11M	14M	7M	8M
Current Portion of Long-Term Debt	-	-	97M	-	139M
Current Portion of Leases	27M	10M	10M	10M	14M
Current Income Taxes Payable	25M	23M	62M	47M	44M
Other Current Liabilities	103M	461M	33M	33M	65M
Total Current Liabilities	557M	780M	572M	338M	609M
Long-Term Debt	630M	609M	548M	537M	1.09B
Long-Term Leases	116M	49M	44M	36M	52M
Pension & Other Post Retirement Benefits	158M	130M	118M	111M	128M
Deferred Tax Liability Non Current	44M	51M	30M	19M	201M
Other Non Current Liabilities	11M	12M	5M	2M	60M
Total Liabilities	1.52B	1.63B	1.32B	1.04B	2.14B
Common Stock, Total	117M	117M	117M	117M	139M
Additional Paid In Capital	407M	407M	408M	408M	942M
Retained Earnings	783M	865M	513M	623M	473M
Comprehensive Income and Other	152M	230M	151M	90M	36M
Total Common Equity	1.46B	1.62B	1.19B	1.24B	1.59B
Minority Interest	1M	1M	1M	1M	-2M
Total Equity	1.46B	1.62B	1.19B	1.24B	1.59B
Total Liabilities And Equity	2.98B	3.25B	2.51B	2.28B	3.73B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	398M	398M	398M	396M	442M
ECS Total Common Shares Outstanding	398M	398M	398M	396M	442M
Book Value / Share	3.66	4.07	2.99	3.13	3.6
Tangible Book Value	1.1B	1.34B	758M	851M	794M
Tangible Book Value Per Share	2.78	3.36	1.91	2.15	1.8
Total Debt	788M	679M	713M	590M	1.31B
Net Debt	417M	569M	238M	153M	972M
Debt Equivalent of Unfunded Proj. Benefit Obligation	83M	95M	100M	82M	100M
Debt Equivalent Oper. Leases	8M	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	1M	1M	1M	1M	-2M
Equity Method Investments, Total	104M	-	199M	165M	-
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	280M	93M	130M	106M	169M
Inventories - Work In Process, Total	21M	20M	38M	20M	110M
Inventories - Finished Goods, Total	231M	204M	278M	227M	302M
Land - (BS)	654M	285M	321M	316M	581M
Machinery, Total	2.56B	979M	1.07B	1.09B	1.72B
Full Time Employees	4.44K	4.59K	3.6K	3.32K	4.97K
Accumulated Allowance for Doubtful Accounts (Supple)	9M	12M	12M	7M	6M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	253M	236M	190M	188M	143M
Depreciation & Amortization - CF	142M	74M	59M	58M	86M
Amortization of Goodwill and Intangible Assets - (CF)	33M	26M	23M	23M	29M
Depreciation & Amortization, Total	175M	100M	82M	81M	115M
Amortization of Deferred Charges, Total - (CF)	-	-	13M	13M	13M
(Gain) Loss From Sale Of Asset	-	13M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	6M	26M	-88M	-48M	-32M
(Income) Loss On Equity Investments - (CF)	-26M	-8M	24M	-25M	-8M
Stock-Based Compensation (CF)	8M	12M	20M	13M	12M
Net Cash From Discontinued Operations	-	4M	-84M	-24M	72M
Other Operating Activities, Total	-23M	-30M	19M	3M	-159M
Change In Accounts Receivable	-38M	-151M	-55M	36M	6M
Change In Inventories	-27M	-147M	-118M	78M	22M
Change In Accounts Payable	40M	79M	71M	-103M	-15M
Change in Other Net Operating Assets	1M	-31M	-8M	-4M	-5M
Cash from Operations	369M	103M	66M	208M	164M
Capital Expenditure	-134M	-132M	-70M	-101M	-114M
Sale of Property, Plant, and Equipment	5M	-	-	-	-
Cash Acquisitions	-62M	1M	-192M	-	-807M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-18M	-16M	-8M	-9M	-7M
Investment in Marketable and Equity Securities, Total	-1M	0	8M	0	1M
Other Investing Activities, Total	5M	34M	1.1B	90M	297M
Cash from Investing	-205M	-113M	835M	-20M	-630M
Long-Term Debt Issued, Total	154M	2M	1M	-	1.16B
Total Debt Issued	154M	2M	1M	-	1.16B
Long-Term Debt Repaid, Total	-41M	-92M	-16M	-114M	-486M
Total Debt Repaid	-41M	-92M	-16M	-114M	-486M
Repurchase of Common Stock	-5M	-13M	-13M	-25M	-223M
Common Dividends Paid	-137M	-144M	-73M	-76M	-80M
Common & Preferred Stock Dividends Paid	-137M	-144M	-73M	-76M	-80M
Special Dividend Paid	-	-	-497M	-	-
Cash from Financing	-29M	-247M	-598M	-215M	367M
Foreign Exchange Rate Adjustments	-35M	13M	45M	-11M	-4M
Net Change in Cash	100M	-244M	348M	-38M	-103M
Supplemental Items
Cash Interest Paid	22M	21M	25M	24M	37M
Cash Income Tax Paid (Refund)	57M	45M	19M	64M	67M
Levered Free Cash Flow	199M	-1.05B	1.39B	157M	-52M
Unlevered Free Cash Flow	216M	-1.04B	1.41B	170M	-30.12M
Change In Net Working Capital	23M	1.1B	-1.23B	-29M	206M
Net Debt Issued / Repaid	113M	-90M	-15M	-114M	670M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.12	3.28	4.84	6.03	5.22
Return on Total Capital	9.5	4.49	6.63	7.74	6.64
Return On Equity %	17.7	1.69	9.04	14.74	3.18
Return on Common Equity	17.7	1.69	9.05	14.75	3.39
Margin Analysis
Gross Profit Margin %	40.68	49.38	49.97	51.67	52.48
SG&A Margin	6.48	19.13	16.39	16.09	18.49
EBITDA Margin %	17.03	18.18	16.9	18.4	20.51
EBITA Margin %	13	13.75	14.05	15.42	16.13
EBIT Margin %	11.83	11.85	12.74	14.03	14.46
Income From Continuing Operations Margin %	9.01	1.89	7.25	10.87	2.59
Net Income Margin %	9.01	17.16	10.85	11.41	8.24
Net Avail. For Common Margin %	9.01	1.89	7.25	10.87	2.76
Normalized Net Income Margin	7.41	6.32	6.46	9.6	8.13
Levered Free Cash Flow Margin	7.1	-76.55	79.45	9.51	-3
Unlevered Free Cash Flow Margin	7.68	-75.5	80.49	10.34	-1.74
Asset Turnover
Asset Turnover	0.96	0.44	0.61	0.69	0.58
Fixed Assets Turnover	2.45	1.72	3.81	3.24	1.78
Receivables Turnover (Average Receivables)	9.53	5.31	6.99	6.45	6.3
Inventory Turnover (Average Inventory)	3.37	1.64	2.3	1.99	1.77
Short Term Liquidity
Current Ratio	2.34	3.06	2.24	3.22	2.16
Quick Ratio	1.26	0.48	1.43	2.12	1.16
Operating Cash Flow to Current Liabilities	0.66	0.13	0.12	0.62	0.27
Days Sales Outstanding (Average Receivables)	38.29	68.75	52.22	56.78	57.92
Days Outstanding Inventory (Average Inventory)	108.29	222.62	158.96	183.69	206.61
Average Days Payable Outstanding	54.19	158.6	72.82	110.37	70.54
Cash Conversion Cycle (Average Days)	92.39	132.77	138.36	130.09	194
Long Term Solvency
Total Debt/Equity	53.97	41.91	59.92	47.62	82.24
Total Debt / Total Capital	35.05	29.53	37.47	32.26	45.13
LT Debt/Equity	51.1	40.62	49.75	46.25	72.1
Long-Term Debt / Total Capital	33.18	28.62	31.11	31.33	39.56
Total Liabilities / Total Assets	50.94	50.17	52.53	45.71	57.44
EBIT / Interest Expense	12.77	7.09	7.69	10.5	7.17
EBITDA / Interest Expense	19.5	11.43	10.52	14.18	10.46
(EBITDA - Capex) / Interest Expense	14.35	5.7	8.1	9.59	7.2
Total Debt / EBITDA	1.55	2.58	2.34	1.89	3.57
Net Debt / EBITDA	0.82	2.16	0.78	0.49	2.66
Total Debt / (EBITDA - Capex)	2.11	5.18	3.03	2.8	5.18
Net Debt / (EBITDA - Capex)	1.12	4.34	1.01	0.73	3.86
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.6	13.54	27.35	-5.94	5.4
Gross Profit, 1 Yr. Growth %	-9	3.98	28.87	-2.74	7.05
EBITDA, 1 Yr. Growth %	3.02	-16.11	26.5	1.68	17.11
EBITA, 1 Yr. Growth %	1.96	2.16	31.55	2.42	9.8
EBIT, 1 Yr. Growth %	2.79	7.24	36.81	2.67	8.19
Earnings From Cont. Operations, 1 Yr. Growth %	3.27	-70.79	388.46	40.94	-71.88
Net Income, 1 Yr. Growth %	3.27	-6.72	-19.49	-1.05	-23.94
Normalized Net Income, 1 Yr. Growth %	3.42	6.11	30.22	38.25	-0.96
Diluted EPS Before Extra, 1 Yr. Growth %	3.27	-71.19	379.76	44.16	-70.85
Accounts Receivable, 1 Yr. Growth %	0.34	-24.41	24.66	-16.19	36.48
Inventory, 1 Yr. Growth %	16.67	-40.41	40.69	-20.85	64.59
Net Property, Plant and Equip., 1 Yr. Growth %	-7.14	-55.02	13.22	8.2	169.7
Total Assets, 1 Yr. Growth %	4.38	9.57	-22.89	-8.97	63.5
Tangible Book Value, 1 Yr. Growth %	4.34	20.58	-44.18	12.27	-6.7
Common Equity, 1 Yr. Growth %	4.29	11.42	-26.56	4.12	28.43
Cash From Operations, 1 Yr. Growth %	-4.16	-72.09	-35.92	215.15	-21.15
Capital Expenditures, 1 Yr. Growth %	-4.96	-1.49	-46.97	44.29	12.87
Levered Free Cash Flow, 1 Yr. Growth %	26.71	-1.28K	-221.67	-88.75	-133.07
Unlevered Free Cash Flow, 1 Yr. Growth %	21.15	-1.11K	-224.82	-87.92	-117.62
Dividend Per Share, 1 Yr. Growth %	4.05	-39.33	-15.14	3.24	3.66
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.94	-30.93	20.25	9.44	-0.43
Gross Profit, 2 Yr. CAGR %	-3.92	-26.44	15.76	11.95	2.04
EBITDA, 2 Yr. CAGR %	3.29	-26.6	-0.34	13.79	9.3
EBITA, 2 Yr. CAGR %	4.23	-27.34	15.31	16.55	6.26
EBIT, 2 Yr. CAGR %	5.91	-28.96	21.12	19.05	5.62
Earnings From Cont. Operations, 2 Yr. CAGR %	18.23	-67.42	19.46	162.39	-40.47
Net Income, 2 Yr. CAGR %	18.23	-1.85	-13.34	-10.75	-13.25
Normalized Net Income, 2 Yr. CAGR %	5.53	-34.3	17.54	34.91	11.08
Diluted EPS Before Extra, 2 Yr. CAGR %	18.07	-67.5	17.58	162.98	-38.63
Accounts Receivable, 2 Yr. CAGR %	0.68	-12.91	-2.92	2.22	6.95
Inventory, 2 Yr. CAGR %	10.72	-16.62	-8.44	5.53	14.14
Net Property, Plant and Equip., 2 Yr. CAGR %	6.08	-35.37	-33.54	10.68	70.82
Total Assets, 2 Yr. CAGR %	3.22	6.78	-8.08	-16.22	21.99
Tangible Book Value, 2 Yr. CAGR %	-1.85	12.32	-17.29	-20.84	2.35
Common Equity, 2 Yr. CAGR %	-1.01	7.58	-9.54	-12.55	15.64
Cash From Operations, 2 Yr. CAGR %	5.74	-48.28	-57.71	42.11	57.63
Capital Expenditures, 2 Yr. CAGR %	14.06	-3.24	-27.72	-12.53	27.62
Levered Free Cash Flow, 2 Yr. CAGR %	-2.27	158.71	294.82	-62.99	-80.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	-2.78	141.58	269.91	-61.16	-85.39
Dividend Per Share, 2 Yr. CAGR %	2.35	-20.54	-28.24	-6.4	3.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.18	-20.68	-15.3	10.79	8.08
Gross Profit, 3 Yr. CAGR %	-1.56	-18.12	-11.33	9.23	10.29
EBITDA, 3 Yr. CAGR %	3.11	-17.67	-13.92	0.56	15.01
EBITA, 3 Yr. CAGR %	4.27	-17.45	-11.76	11.14	14.4
EBIT, 3 Yr. CAGR %	5.59	-18.03	-11.62	14.97	15.48
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.28	-47.63	-19.67	26.23	20.06
Net Income, 3 Yr. CAGR %	-1.53	9.25	-8.13	-9.42	-15.38
Normalized Net Income, 3 Yr. CAGR %	5.33	-22.53	-17.47	24.53	17.55
Diluted EPS Before Extra, 3 Yr. CAGR %	-1.38	-47.76	-20.27	25.84	21.8
Accounts Receivable, 3 Yr. CAGR %	3.51	-8.49	-1.85	-7.56	12.56
Inventory, 3 Yr. CAGR %	8.28	-9.94	-0.74	-12.78	22.38
Net Property, Plant and Equip., 3 Yr. CAGR %	4.62	-20.31	-25.71	-21.82	48.94
Total Assets, 3 Yr. CAGR %	5	5.19	-4.2	-8.38	4.7
Tangible Book Value, 3 Yr. CAGR %	3.14	5.22	-10.55	-8.42	-16.38
Common Equity, 3 Yr. CAGR %	2.19	2.83	-5.28	-5.2	-0.6
Cash From Operations, 3 Yr. CAGR %	8.86	-32.17	-44.45	-17.39	16.77
Capital Expenditures, 3 Yr. CAGR %	6.48	8.62	-20.82	-8.99	-4.77
Levered Free Cash Flow, 3 Yr. CAGR %	3.11	71.51	106.83	20.62	-64.31
Unlevered Free Cash Flow, 3 Yr. CAGR %	2.65	65.74	99.36	18.26	-70.12
Dividend Per Share, 3 Yr. CAGR %	2.38	-14.02	-18.78	-18.99	-3.16
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.57	-12.96	-8.36	-9.78	-9.64
Gross Profit, 5 Yr. CAGR %	3.62	-10.02	-6.07	-7.21	-6.21
EBITDA, 5 Yr. CAGR %	10.82	-8.93	-7.45	-7.52	-5.16
EBITA, 5 Yr. CAGR %	12.12	-8.21	-5.24	-5.44	-4.8
EBIT, 5 Yr. CAGR %	14.19	-8.2	-4.59	-4.84	-4.92
Earnings From Cont. Operations, 5 Yr. CAGR %	15.9	-36.66	-13.55	-0.22	-28.75
Net Income, 5 Yr. CAGR %	9.19	-1.61	-6.44	0.76	-10.21
Normalized Net Income, 5 Yr. CAGR %	13.6	-11.57	-8.68	-3.29	-6.85
Diluted EPS Before Extra, 5 Yr. CAGR %	15.74	-36.71	-13.99	-0.28	-28.2
Accounts Receivable, 5 Yr. CAGR %	4.39	-2.26	0.89	-4.35	1.58
Inventory, 5 Yr. CAGR %	6.46	-6.39	1.26	-4.05	4.96
Net Property, Plant and Equip., 5 Yr. CAGR %	3.6	-14.07	-12.75	-11.67	3.66
Total Assets, 5 Yr. CAGR %	3.11	3.25	-0.5	-3.96	5.53
Tangible Book Value, 5 Yr. CAGR %	11.61	7.49	-5.52	-5.8	-5.6
Common Equity, 5 Yr. CAGR %	7.25	3.98	-2.75	-3.62	2.59
Cash From Operations, 5 Yr. CAGR %	14.44	-19.14	-25.42	-8.82	-15.69
Capital Expenditures, 5 Yr. CAGR %	-5.63	0.78	-8.81	-0.39	-4.16
Levered Free Cash Flow, 5 Yr. CAGR %	48.6	71.96	50.24	-5.57	-19.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	38.77	64.47	47.89	-5.66	-29.89
Dividend Per Share, 5 Yr. CAGR %	1.92	-7.77	-11.19	-11.05	-10.53